Efficacy of 96 weeks adefovir dipivoxil treatment in HBeAg positive chronic hepatitis B patients with various baseline biochemical levels

被引：0
|
作者：
Zhuang, L. [1 ]
You, J. [2 ]
Kong, L. [1 ]
Lei, H. [1 ]
Yang, R. -D [2 ]
Zhang, X. [2 ]
Wang, Q. -Q [2 ]
机构：
[1] Third Municipal Peoples Hosp Kunming, Kunming, Peoples R China
[2] Kunming Med Univ, Affiliated Hosp 1, Kunming, Peoples R China
来源：
INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES | 2010年 / 14卷
关键词：
D O I：
10.1016/j.ijid.2010.02.2015
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：E236 / E237
页数：2
相关论文
共 50 条
  • [1] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B patients with various baseline biochemical levels: Results from 4 years adefovir dipivoxil treatment
    Zhuang, L.
    You, J.
    Kong, L.
    Li, Y. L.
    Lei, H.
    Ma, Y. L.
    Chen, H. Y.
    Liu, H. E.
    Feng, X.
    Ma, S. J.
    Huang, J. H.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    Yan, S. M.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2014, 21 : 319 - 319
  • [2] Long-term therapy with adefovir dipivoxil for HBeAg positive chronic hepatitis B: results from 144 weeks adefovir dipivoxil treatment
    You, J.
    Zhuang, L.
    Chen, H. Y.
    Feng, X.
    Kong, L.
    Lei, H.
    Ma, Y. L.
    Li, Y. L.
    Yang, W. B.
    Huang, J. H.
    Yan, S. M.
    Che, Y. H.
    Wang, Q. Q.
    Chen, L.
    [J]. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2011, 15 : S30 - S30
  • [3] EVALUATION OF THE EFFICACY OF ENTECAVIR VERSUS ADEFOVIR IN HBEAG-POSITIVE CHRONIC HEPATITIS B PATIENTS THERAPY AT 96 WEEKS
    Sun, Aimin
    Cheng, Haowei
    Zhao, Liqun
    Yang, Huiyu
    Yang, Guojie
    [J]. HEPATOLOGY, 2010, 52 (04) : 550A - 550A
  • [4] Histological improvement in HBeAg positive chronic hepatitis B patients treated with adefovir dipivoxil
    Marcellin, P
    Goodman, Z
    Chang, TT
    Lim, SG
    Tong, MR
    Sievert, W
    Shiffman, M
    Jeffers, L
    Wulfsohn, M
    Fallis, R
    Fry, J
    Brosgart, C
    [J]. JOURNAL OF HEPATOLOGY, 2002, 36 : 8 - 8
  • [5] Five years of treatment with adefovir dipivoxil in Chinese patients with HBeAg-positive chronic hepatitis B
    Zeng Minde
    Mao Yimin
    Yao Guangbi
    Hou JinLin
    Wang Hao
    Ren Hong
    Wang Yuming
    Zhou Xiaqiu
    Xu Daozhen
    Chen Yagang
    Niu Junqi
    Chen Youming
    Wang Yaozong
    Dixon, Jonathan
    Barker, Keith
    [J]. LIVER INTERNATIONAL, 2012, 32 (01) : 137 - 146
  • [6] Long-term efficacy and safety of adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B (CHB) patients
    Marcellin, Patrick
    Chang, Ting-Tsung
    Lim, Seng Gee
    Sievert, William
    Tong, Myron
    Arterburn, Sarah
    Borroto-Esoda, Katyna
    Chuck, Steven
    [J]. HEPATOLOGY, 2006, 44 (04) : 548A - 548A
  • [7] Lamivudine compared with lamivudine and adefovir dipivoxil for the treatment of HBeAg-positive chronic hepatitis B
    Sung, Joseph J. Y.
    Lai, Jak-Yiu
    Zeuzem, Stefan
    Chow, Wan Chen
    Heathcote, E. Jenny
    Perrillo, Robert P.
    Brosgart, Carol. L.
    Woessner, Mary A.
    Scott, Susan A.
    Gray, D. Fraser
    Gardner, Stephen D.
    [J]. JOURNAL OF HEPATOLOGY, 2008, 48 (05) : 728 - 735
  • [8] Efficacy and safety of telbivudine plus adefovir dipivoxil combination therapy and entecavir monotherapy for HBeAg-positive chronic hepatitis B patients with resistance to adefovir dipivoxil
    Lu, Jia-Jie
    Liu, Kai
    Ma, Yuan-Ji
    Wang, Juan
    Chen, En-Qiang
    Tang, Hong
    [J]. JOURNAL OF VIRAL HEPATITIS, 2013, 20 : 40 - 45
  • [9] Adefovir dipivoxil (ADV), 10 mg for the treatment of patients with HBeAg plus chronic hepatitis B: Continued efficacy beyond 48 weeks.
    Marcellin, P
    Chang, TT
    Lim, SG
    Sievert, W
    Tong, M
    Jain, A
    James, C
    Chen, SS
    Fry, J
    Brosgart, C
    [J]. HEPATOLOGY, 2002, 36 (04) : 373A - 373A
  • [10] Efficacy and safety of 2 years adefovir dipivoxil (ADV) in Chinese patients with HBeAg positive chronic hepatitis B (CHB)
    Zeng, M. D.
    Mao, Y. M.
    Yao, G. B.
    Wang, H.
    Hou, J. L.
    Wang, Y. Z.
    Dixon, J. S.
    Barker, K. F.
    [J]. JOURNAL OF HEPATOLOGY, 2006, 44 : S185 - S185
12345